Antimicrobial resistance results in increased morbidity, mortality, and costs of health care. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.
Antimicrobial resistance results in increased morbidity, mortality, and costs of health care. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.
• Establish practice guidelines and other institutional poliSummary cies to control the use of antibiotics, and respond to data from the monitoring system; Antimicrobial resistance results in increased morbidity, mor-
• Adopt the recommendations of the Centers for Disease tality, and costs of health care. Prevention of the emergence Control and Prevention (CDC) ''Guidelines for Isolation Preof resistance and the dissemination of resistant microorganisms cautions in Hospitals,'' as concerns the isolation of patients will reduce these adverse effects and their attendant costs. Apcolonized or infected with resistant microorganisms; propriate antimicrobial stewardship that includes optimal selec-
• Utilize hospital committees to develop local policies and tion, dose, and duration of treatment, as well as control of to evaluate and adopt, as appropriate, guidelines from state antibiotic use, will prevent or slow the emergence of resistance advisory boards and national societies; among microorganisms. A comprehensively applied infection
• Recognize that the financial well-being of the institution control program will interdict the dissemination of resistant and the health of its patients are at stake and therefore that the strains. It therefore is recommended that hospitals, large and hospital administration should be accountable for the implesmall, with and without perceived problems of bacterial resismentation and enforcement of policies adopted by hospital tance to antimicrobials, do the following:
committees; • Establish a system for monitoring bacterial resistance
• By measuring outcomes, evaluate the effectiveness of and antibiotic usage; the policies that are put in place. It is recommended that research to define the mechanism of transfer of bacteria and their resistance determinants among patient populations and to determine methods to prevent emer-
Epidemiology of America (SHEA) and the Infectious Diseases
One critical area requiring immediate attention is the existing database from which these and other guidelines are constructed. Society of America (IDSA) have embarked on a joint project to make recommendations regarding the prevention and control Clear recommendations have been made regarding further research that might provide the kind of data needed for rational of antimicrobial resistance. This task has assumed very broad boundaries and includes the prevention of emergence and condecisions in the management of antimicrobial usage and infection control. trol of dissemination of antibiotic-resistant pathogens in hospitals, in other institutions, in outpatient settings, and in both animal and human health.
Emergence of Antimicrobial Resistance in Hospitals There is convincing evidence that we share a single ecosys-
Genetics of Resistance
tem globally in terms of resistance. The selection of resistance in one organism in one part of the world, even within an animal Bacteria possess a remarkable number of genetic mechanisms for resistance to antimicrobials. They can undergo chropopulation, may have long-term, important implications for human health globally. Therefore, management of the problem mosomal mutations, express a latent chromosomal resistance gene, or acquire new genetic resistance material through direct of antimicrobial resistance within hospitals is a community responsibility, both within and outside of the hospital. The exchange of DNA (by conjugation), through a bacteriophage (transduction), through extrachromosomal plasmid DNA (by following recommendations are directed toward all hospitals, small to large, with and without currently perceived problems conjugation), or by acquisition of DNA via transformation. The information encoded in this genetic material enables a with antibiotic resistance. Good stewardship of antibiotic usage combined with strong infection control will be required. To bacterium to develop resistance through three major mechanisms: production of an enzyme that will inactivate or destroy achieve this, all levels of personnel within the hospital must be involved, from top administration down to individuals perthe antibiotic; alteration of the antibiotic target site to evade action of the antibiotic; or prevention of antibiotic access to forming services and providing patient care. The recommendations promulgated in this set of guidelines reflect this approach.
the target site. Examples of organisms that are known to possess resistance mechanisms of the various types are shown in table This report, the first of a series that is emerging from this joint committee on antibiotics, is concerned with two major aspects of 1, together with the genetic mechanism for the resistance [3] . It is not unusual for a single bacterial strain found in a hospital antibiotic resistance in hospitals: the selection of antibiotic-resistant organisms and the dissemination of resistance within the to possess several of these resistance mechanisms simultaneously. hospital setting. The basic genetics of bacterial resistance and the breadth of possibilities available to microorganisms to avoid the Some resistance can be acquired by a single genetic mutation that can occur spontaneously, such as the DNA gyrase target toxic effects of antibiotics are reviewed. Various methods of surveillance for resistance in the hospital are considered, and criteria alteration that results in fluoroquinolone resistance. Other resistance mechanisms are far more complex and consist of genes that hospitals might use to identify resistant organisms of epidemiological importance are developed. The critical role of antibiotic that encode production of highly specific enzymes that inactivate several antibiotics (e.g., b-lactams or aminoglycosides). use in the hospital in the selection of resistant bacteria is reviewed, and recommendations designed to avoid or retard the selection There is considerable speculation about the origin of these genes. Some genes can be found naturally occurring in other of resistant bacteria are provided. Specific isolation procedures for patients infected or, in some cases, colonized with resistant species of bacteria [4] . It is postulated that there is a substantial pool of antibiotic resistance genes (or related genes) in nature. organisms that the hospital has chosen to attempt to control also are reviewed.
This gene pool, to be of use to bacteria that are under selective antibiotic pressure, must be accessible, and the bacteria must That infection control committees of hospitals have been struggling with these problems for many years is clear, and possess the means to acquire the needed genetic information (gene pickup). many feel frustrated with a real or perceived lack of administrative support. The relation between infection control and the Transposons (so-called jumping genes) and plasmids provide two readily available means for gene transfer. One class of hospital administration regarding these recommendations is examined. It is clear that, without the support of the administratransposons, called integrons, consists of conserved DNA segments that flank a central region into which ''cassettes'' that tion, neither these recommendations nor those of local infection control committees will be of use in the struggle against antibiencode antibiotic-resistance functions can be inserted. The 5 conserved segment encodes a site-specific recombinase or inotic resistance. The guidelines seek to motivate administrators to invest in the infection control effort, given the convincing tegrase, as well as one or more promoters that assure expression of the integrated resistance cassettes. Integron-type transposons financial arguments favoring the control of antimicrobial resistance. We also provide an organizational framework for adminprovide a model for assembly of multiple antibiotic resistance genes from a variety of sources into R plasmids that have istrators so that they can appreciate their role as part of a team involved in providing the most efficient and highest-quality been found to display an ever-increasing array of resistance properties [4, 5] . care for patients in their institutions. 
Virulence of Resistant Bacteria
Transposable elements and plasmids encode not only genetic information for inactivation of antimicrobials, they also may Although it often has been stated that antibiotic-resistant bacencode genes for the active efflux of antibiotics from the cell, teria tend to be less virulent than their susceptible parents [9] , the so-called sump pump mechanism of resistance. Efflux systhis is not necessarily true, and even less virulent bacteria can tems may be highly specific for single agents or may involve be dangerous pathogens for some hospitalized patients. For exa variety of classes of antimicrobial agents. Many of the resisample, bacteria that acquire mutations in genes responsible for tances previously thought to be due to permeability barriers vital functions, such as transport of small molecules, can be subsequently have been found to be mediated by efflux pumps resistant to some antibiotics, such as aminoglycosides, and tend [6, 7] .
to be less virulent in animal models of infection [10] . However, Whereas some altered target-site resistance may be due to some authors argue that such bacteria can be responsible for single mutations, as occur with fluoroquinolones and rifampin, relapse of infection after treatment, because they are not treated target-site alterations for b-lactam resistance are more comeffectively by the antibiotic nor are they cleared effectively by plex. Penicillins, cephalosporins, and other b-lactams act by impaired host defenses [11] . Many resistant pathogens appear inactivating a number of transpeptidases (or penicillin-binding just as virulent as the susceptible parents in animal models and proteins [PBPs] ) essential for the cross-linking reactions of in patients, as is the case for methicillin-resistant S. aureus cell-wall synthesis [8] . Because there often are multiple PBP (MRSA), for example [12] . Therefore, antimicrobial resistance targets, resistance development is slow and often stepwise as per se may not render pathogenic bacteria easier to clear from each PBP is altered in its affinity for the b-lactam. Developinfected sites. Further, there is evidence that they are transmitted ment of resistance may occur gradually with the slow accumufrom patient to patient in much the same way as susceptible lation of multiple amino acid substitutions through mutations; bacteria, i.e., mainly through contact and occasionally through however, there also is evidence to support the acquisition of airborne droplets (see below) [13, 14] . low-affinity PBP genes in Neisseria gonorrhoeae and Neisseria meningitidis from recombination with commensal Neisseria Surveillance for Resistant Bacterial Pathogens species. In the case of methicillin resistance in Staphylococcus aureus, a new PBP 2 or mecA gene, which is part of a transpo-A major role of the clinical microbiology laboratory is to provide antimicrobial susceptibility testing data on bacterial son, has been acquired by the Staphylococcus.
Clearly, bacteria have evolved a wide array of mechanisms isolates to guide clinicians in their choice of anti-infective therapy. Susceptibility testing data can serve both as a guide to become resistant to antimicrobials and are adept at disseminating the resistance once it has been acquired. Analysis of to therapy and, in some instances, as an initial means of strain typing for investigations of potential outbreaks of infection. organisms from the preantibiotic era suggests that evolution of multiresistant R plasmids has occurred over the past 50 years, Other strain typing methods, such as pulsed-field gel electrophoresis, have better discriminatory ability. However, unusual a period that happens to coincide with the discovery and increasingly widespread use of antimicrobial agents. A causal antibiograms, especially multiply resistant patterns, can be helpful early in the course of an investigation for identifying association between these two temporally related phenomena is quite probable.
outbreak-related isolates. In conjunction with routine antimicrobial susceptibility testing for guiding antimicrobial chemotherapy, microbiologists Prioritizing of susceptibility reports, in which extended-specalso frequently are involved in programs for the surveillance of organisms with novel resistance patterns. There are two and spread within the population is more likely. The same concept might explain resistance problems in the poultry manufacturing industry and in other settings where antibiotic use is intensive within a small and confined population. selection of resistant subpopulations. Often, the introduction of a resistant organism can be documented by contact tracing
The growing emphasis on outpatient medical management has increased the severity of illness of those who are admitted to an index case that was admitted to the hospital already infected or colonized with the resistant organism. More freto the hospital. Patients with advanced malignancies, organ transplantation, multiorgan failure, or human immunodefiquently, however, the source of resistant organisms remains an enigma. Although the exact magnitude of the problem due ciency virus infection are far more immunocompromised and constitute a larger portion of hospital patients than in the past. to the spread of resistant organisms within the institution is unknown, it is clear that such spread can be minimized by These patients often are colonized or infected with unusual opportunistic organisms that are far more resistant to antimicroearly recognition and effective infection control practices. Regrettably, recognition of cross-infection often is slow, and conbials -organisms such as Pseudomonas, Stenotrophomonas, Acinetobacter, Enterobacter, Serratia, coagulase-negative tainment and control measures often are inadequate or ineffective.
staphylococci, enterococci, Candida, phycomycetes, and Aspergillus [20] . These patients also are more likely to be treated Several lines of evidence suggest that there is a causal association between antimicrobial usage in hospitals and antimicrowith procedures (such as bone marrow transplantation) and devices (indwelling urinary and intravascular catheters) that bial resistance [16] . For some pathogens, selection of resistance during treatment or prophylaxis is thought to be a more imincrease the risk of infection by specific organisms. Increased treatment of patients in the community can lead to resistance portant factor in the acquisition of infection by a resistant organism than is transmission from patient to patient [17] .
in the community that is introduced to the hospital by patients on admission; methicillin-resistant staphylococci and ampicilAdditional compelling observations are as follows:
1. Changes in antimicrobial usage are paralleled by lin-resistant Haemophilus organisms are examples. Infection control and isolation practices vary from hospital to hospital. changes in the prevalence of resistance.
2. Antimicrobial resistance is more prevalent in nosocoTheir effective use can have considerable influence on reducing the persistence and spread of resistant organisms in the hospital. mial bacterial strains than in those from community-acquired infections.
Changes in antimicrobial usage also may influence resistance. Policies such as systemic and gastrointestinal antimicrobial 3. During outbreaks of nosocomial infection, patients infected with resistant strains are more likely than control patients prophylaxis in intensive-care units [21] and empiric polyantimicrobial treatment of febrile immunocompromised, as to have received prior antimicrobials.
4. Areas within hospitals that have the highest rates of well as immunocompetent, patients [22, 23] , may add to the risk of antimicrobial resistance in hospital organisms. Taken antimicrobial resistance also have the highest rates of antimicrobial use.
5. Increasing duration of patient exposure to antimicrobials increases the likelihood of colonization with resistant organ- isms [16] .
The above observations are derived from review of multiple Notwithstanding the complexity of the problem and the need of antimicrobial use per geographic unit per unit time) has been suggested as an evaluation measure that could be useful in for better data-controlled studies, there nonetheless are sufficient reports of the association of antimicrobial usage in hospirelating resistance to use of antimicrobials [19] . The elements suggested for inclusion in an effective antimitals with emergence of antimicrobial resistance to implicate use as a causal factor in antimicrobial resistance [15, 16, 18, crobial control program to prevent or reduce antimicrobial resistance are shown in table 5. Because of the complexity of 20, 25 -28]. Clearly, the degree to which such resistance occurs, and the organisms and drugs affected, is quite variable multidrug resistance in many organisms, it can be predicted that not all control measures will succeed. For this reason, it and not predictable for most drug-organism pairs. This is illustrated by the observation that the rate of ciprofloxacin resistance is recommended that monitoring include many of the variables listed in table 5 (such as mechanism of resistance, molecular among MRSA is markedly higher than for methicillin-sensitive S. aureus or gram-negative organisms [28] . In this case, the typing of organisms, and complete resistance profiles), so that insights can be obtained regarding which control strategies ciprofloxacin resistance mechanism has been determined, but it is not clear why these mutational changes apparently are are more likely to succeed than others. For example, multiply antimicrobial-resistant organisms may respond to control of more frequent in MRSA than in other organisms [29 -31] . Thus, we need to examine carefully not only the relation of one agent to which they are resistant, but they may not respond to control of other agents to which they also are resistant. resistance to antimicrobial use for specific organism-drug pairs but also to determine the mechanism of that resistance as an Initial control efforts are likely to be empiric, simply because the best strategies are not known yet. Uncontrolled resistance indicator of possible causation.
no longer can be tolerated. Managed-care networks are likely to demand control of resistance to improve patient-care quality
Prevention of Emergence of Resistance
and to reduce costs of health care. It is likely, given the trend toward greater outpatient care, that prevention and control of Prevention of the emergence of antimicrobial resistance and reduction of established resistance are dual goals for which antimicrobial resistance will be as important in the outpatient arena as in the inpatient setting. the methods are likely similar if not identical. Preventing the acquisition of resistance is assumed to be the easier task, al-
The ideal is to have all patients treated with the most effective, least toxic, and least costly antibiotic for the precise durathough data regarding preventive strategies generally are lacking, whereas studies of actions taken once resistance has oction of time needed to cure or prevent an infection. This is the essence of good antimicrobial use stewardship. Four possible curred are plentiful, if not consistent, regarding their efficacy. The elements of a good program for prevention of resistance strategies to optimize use are shown in table 6. The first of these involves the development of guidelines and treatment generally include an active system of surveillance for resistance, an active and effective infection control program to minialgorithms, designed to elucidate ''pathways'' of optimal use. mize secondary spread of resistance, and an effective program of antimicrobial use stewardship. The latter element, sometimes Table 6 . Proposed methods to control antimicrobial use to prevent tance in three institutions [34, 37, 46] . Gentamicin use in one or control antimicrobial resistance. of these institutions was reinstituted successfully, subsequently, at a time when the original resistance plasmid no longer was Optimal use of all antimicrobials found in hospital organisms [34] . The potential of this strategy Selective removal, control, or restriction of antimicrobial agents or classes Rotational or cyclic antimicrobial use as a resistance prevention measure has not been explored adeUse of combination antimicrobial therapy to prevent the emergence of quately, but it is a distinctly testable hypothesis in intensiveresistance care units. In addition to the caveats expressed previously regarding such attempts [45] , it also is important to note that the duration of the cycles and the preferred order in which agents are cycled is unknown. Testing this method will require a Prescribers are educated to follow them and to seek expert guidance along the way from infectious disease specialists and multicenter trial, because a large population will be needed to control for several confounding variables. pharmacists. To date, such programs have not been particularly effective, even with the addition of peer review [32] .
The last strategy suggested in table 6, use of combination antimicrobial therapy to reduce emergence of resistance, is The second method of antimicrobial control, selective removal or control of use of specific agents or classes of agents, theoretically attractive and is the basis for current treatment of tuberculosis with multiple antimicrobials. It has not been has been employed in numerous hospitals. Compliance with the restriction policy easily can be documented from pharmacy adequately tested clinically to determine if overall institutional resistance can be reduced by the use of combination therapy prescribing data, and favorable effects on the incidence and prevalence of specific resistant organisms have been docufor individual patients [47] . In one study of Enterobacter, no benefit in reducing emerging resistance was observed when mented [32 -40] . More studies have been conducted on control of gentamicin resistance (mainly through the restriction of gencombined third-generation cephalosporin and aminoglycoside therapy was used [48] . The risks include increased antimicrotamicin and replacement with amikacin) than on any other antimicrobial [33 -38] . Most have shown significant reductions bial costs and the potential for increasing resistance by raising the number of antimicrobials and antimicrobial courses adminin gentamicin resistance during restriction, but return of resistance with resumption of gentamicin use [34 -36] . In some istered. The use of combination therapy is, however, already widespread for the treatment of seriously ill patients, so coninstances when this ''replacement'' strategy was employed, resistance to amikacin developed, and resistance problems betrolled trials to determine the effect on resistance prevention are reasonable. came worse [41 -43] ; however, in most institutions, this did not occur [33 -38, 44] . Although such studies often were comIn summary, antimicrobial resistance among some hospital organisms has increased to the point that no antimicrobials are mercially sponsored to promote use of an alternative product, they still provide a model for future efforts to control antimicroavailable for treatment. This is a situation that cannot be tolerated. The need for preventive and corrective measures is urgent. bials in that the protocols employed for monitoring resistance and antimicrobial use in each institution were similar. In most There is an almost certain causal association between the use of antimicrobials and resistance to them. Alterations in antimiinstances, the mechanism of resistance to gentamicin was determined (usually plasmid-mediated transferable aminoglycoside crobial usage have been shown to affect antimicrobial resistance rates, particularly for the aminoglycosides. Additional inactivating enzymes), and the potential mechanism for amikacin resistance (a different aminoglycoside inactivating enlarge-scale, well-controlled trials of regulation of antimicrobial use employing sophisticated epidemiological methods, molecuzyme) was monitored [34 -36] . Control measures were enforced rigidly and resulted in major usage changes, as had been lar typing of organisms, and precise analysis of mechanisms of resistance are required to determine the best methods to described by others [39] . Organisms and plasmids were typed using molecular techniques, so that the presence of resistance prevent and control this emerging problem of antimicrobial resistance and to establish optimal antimicrobial use. genes in hospital organisms could be determined during and after antimicrobial changes [34] . Future studies should build on the wide experience of these studies in exploring the effect Controlling the Dissemination of Resistant Bacteria in of control measures on resistance prevention and reduction. Hospitals The pharmaceutical industry should be encouraged to explore ways in which they can provide support for studies that can
The SHEA/IDSA Joint Committee on Antibiotics supports the CDC ''Guideline for Isolation Precautions in Hospitals'' [13] lead to preservation of the effectiveness of their drugs in the clinical setting.
as it applies to preventing the selection and spread of resistant microorganisms. Our recommendations are summarized in It is recommended that hospitals have a system for monitoring antimicrobial resistance of both community and nosocomial A III isolates (by hospital location and patient site) on a monthly basis or at a frequency appropriate to the volume of isolates. Monitoring use of antimicrobials by hospital location or prescribing service is recommended on a monthly basis or at a A III frequency appropriate to the prescription volume. It is recommended that hospitals monitor the relationship between antimicrobial use and resistance, and assign A II responsibility through practice guidelines or other institutional policies. It is recommended that hospitals apply Contact Precautions to specified patients known or suspected to be colonized or A III infected with epidemiologically important microorganisms that can be transmitted by direct or indirect contact.
* Categories for strength of recommendation: A, good evidence for support; B, moderate evidence for support; C, poor evidence to support. † Categories reflecting the quality of evidence on which recommendations are based: I, evidence from at least one properly randomized controlled trial; II, evidence from at least one well-designed clinical trial without randomization, from cohort or case-controlled analytic studies (preferably from more than one center), from multiple time-series studies, or from dramatic results in uncontrolled experiments; III, evidence from opinions of respected authorities, based on clinical experience, descriptive studies, or reports from expert committees.
hospitals [49] . Beyond this clear recommendation, hospitals program, based on current state, regional, or national recommendations, to be of special clinical and epidemiological again will have to make choices. Will colonized patients be isolated, for example? In general, it is recommended [13] that significance. In its most rigorous form, this should include a quantitative susceptibility testing system that is better able hospitals choose which organisms are of special clinical and epidemiological importance to identify patients for isolation.
to detect resistance than a simple breakpoint testing system. Under such a system, any epidemiologically important isoThat such policies be adopted and implemented is especially important for hospitals where such resistance is not yet perceived late with an unusual and relevant (for the hospital) decrease in susceptibility to one or more antibiotics might prompt as problematic. How should hospitals carry out surveillance for resistant microorganisms to identify patients requiring isolation? institution of isolation precautions for the colonized or infected patient. An example might be K. pneumoniae isolated These questions are discussed below.
from the sputum of a patient with pneumonia that has an MIC for cefotaxime or ceftriaxone of 2 mg/mL. Although
The Colonized Patient this ordinarily might be called susceptible by the hospital The recommendations from the CDC [13] are unclear on laboratory and by currently accepted U.S. laboratory guidehow to care for patients colonized with resistant organisms.
lines, such as those furnished by the NCCLS, this MIC cerThe most conservative approach is to isolate patients colonized tainly is unusual for the species. Identifying such an isolate with those organisms the hospital has decided to control, bejustifiably might call for isolation of the patient, especially cause they may be an important reservoir for transmission to, because it is unlikely that treatment with cefotaxime or cefand eventually infection of, other patients or even health care triaxone would be successful [50] . A simple, user-friendly workers. On the other hand, colonized patients are difficult to data entry and retrieval system called WHONET has been identify, likely to have a smaller burden of organisms than supported by the World Health Organization for use by hosinfected patients, and therefore are less likely to be a source pitals that wish to survey quantitative susceptibility tests of transmission. Isolation, or even cohorting, of every patient (MICs or zone sizes) [51] . A recent feature of this system colonized with a resistant, epidemiologically important microcalls attention to unusual drug resistance as the results are organism may not be practical for some hospitals. When possibeing entered. ble, patients colonized with such an organism, whether they Hospitals should consider instituting isolation precautions for have been recognized through a surveillance effort or by patients colonized or infected with multiply resistant microorchance, should be treated in the same manner as patients cliniganisms. This seems most important for hospitals where resiscally infected with those organisms. Readmission of patients tance is not yet perceived to be a problem, because it is in such colonized with resistant organisms represents a hidden reserhospitals that the emergence of resistance will have the greatest voir that could be monitored and controlled.
impact 
CDC Isolation Precautions for Hospitals
ing the use of antimicrobial agents has been administrative implementation of guidelines and policies designed to change All patients are cared for using Standard Precautions. Stanusage. Implementation, in this context, means the attainment dard Precautions synthesize the major features of Universal of sustained performance of approved standards of good stew-(Blood and Body Fluid) Precautions (designed to reduce the ardship. Effective implementation remains a problem, because risk of transmission of bloodborne pathogens) and Body Subit is not clear what administrative level of approval and enforcestance Isolation (designed to reduce the risk of transmission of ment is needed to ensure sustained positive performance. It pathogens from moist body substances) [52 -54] and apply is likely that a hierarchy of decision-making groups working them to all patients receiving care in hospitals, regardless of together will guarantee implementation of sound antibiotic their diagnosis or presumed infection or colonization status. stewardship guidelines best [55] . Standard Precautions apply to blood [1] , all body fluids, secreIt is important to be aware that control of microbial resistance tions, and excretions, regardless of whether they contain visible is not implemented just through control of antimicrobial use, blood, nonintact skin, and mucous membranes [13] . Standard although this may be an essential component. There are very Precautions are designed to reduce the risk of transmission of few studies on the relative effectiveness of strategies for implemicroorganisms from both recognized and unrecognized mentation of antimicrobial control policies [55] . Most authorisources of infection in hospitals.
ties suggest that the pharmacy and therapeutics (P&T) commitTransmission-Based Precautions. Transmission-Based Pretee should be charged with developing formulary and cautions are designed for patients documented or suspected to antimicrobial controls through a variety of mechanisms. Such be infected or colonized with highly transmissible or epidemiomechanisms often include approval of orders by the infectious logically important pathogens for which additional precautions disease service, use of antibiotic order forms, and use of a beyond Standard Precautions are needed to interrupt transmiscomputerized database to correlate pharmacy and bacteriology sion in hospitals. Of the three types of Transmission-Based results [56] . Ordinarily, the P&T committee submits its poliPrecautions discussed in the Hospital Infection Control Praccies for executive board review and approval, although this tices Advisory Committee (HICPAC) recommendations [13] , measure is often a rubber stamp of the P&T recommendations. only Contact Precautions are thought to be relevant to the The involvement of hospital administration in this process transmission of resistant bacteria other than Mycobacterium varies [57] . tuberculosis. SHEA supports the HICPAC recommendations for the prevention of transmission of resistant pathogens [13] (table 7) .
Approaches to Implementation
Contact Precautions. Contact Precautions are designed to reduce the transmission of epidemiologically important microHistorically, antibiotic control policies have been used to organisms by direct or indirect contact. Direct contact transmiscontrol costs [56 -58] . A side benefit always has been assumed sion involves skin-to-skin contact and physical transfer of mito be reduced selective pressure and thus less antimicrobial croorganisms to a susceptible host from an infected or resistance. Reduction of antimicrobial resistance using costcolonized person, such as occurs when personnel turn a patient, motivated controls has not been documented well [59, 60] . give a patient a bath, or perform other patient-care activities Nevertheless, ''bottom-up'' systems that start with P&T comthat require physical contact. Direct contact transmission also mittees within hospitals have been used with variable success can occur between two patients (e.g., by hand contact), with in controlling antimicrobial use, as long as the control measures one serving as the source of infectious microorganisms and remain in effect or are accepted fully by prescribers [61] . Ultithe other as the susceptible host. Indirect contact transmission mately, regardless of the mechanisms for control, very few involves contact of a susceptible host with a contaminated programs have been able to show changes among prescribers intermediate object, usually inanimate, in the patient's environthat are sustained over a substantial period of time. ment. Clearly, the environment can be an important reservoir Bottom-up approaches have advantages and disadvantages of resistant microorganisms. Contact Precautions apply to specfor implementation of changes. Some advantages include the ified patients known or suspected to be colonized or infected ability to streamline control methods to local resistance probwith epidemiologically important microorganisms that can be lems, the backing of on-site infectious disease practitioners, transmitted by direct or indirect contact. and a democratic procedure involving clinicians, administrators, and other health care workers. Disadvantages include the Implementation of Policy to Control Antibiotic Resistance inability to anticipate national and international resistance trends; the outside pressures brought by physicians, pharmaOverview ceutical buying groups, and pharmaceutical representatives; and the lack of consensus among clinicians and administrative Despite a strategic vision among hospital epidemiologists and tactical tools within hospitals known to be effective in personnel regarding the importance of a broad attack on antibiotic resistance and the roles they should play. limiting antimicrobial use, the most difficult aspect of influenc-/ 9c37$$se39
08-19-97 12:01:09 cida UC: CID Face-to-face-presentations [72] resistance [68, 69] . Previously, cost-benefit analyses could de-
Computer interactions [73] termine which antimicrobial to include or exclude from hospital Pharmacy ''Top 100'' expenditures list formulary use. A more difficult determination using risk-benefit
Restriction of hospital formulary through pharmacy and therapeutics committee analysis -where risk, in part, includes the emergence of antiCyclic rotation of antimicrobials within a class [34] microbial resistance -now has become necessary to decide if Antibiotic order forms [74, 75] an agent should be deleted, restricted, or substituted. Proof mentation of antibiotic control, therefore, remain empirical.
Removal of specific agents [78] Nevertheless, because effective implementation and enforceReview of medical record by pharmacists [79] ment of antibiotic control programs are the essential first steps Decentralized pharmacies to success, it seems prudent to build first a consensus of various PharmDs to interact with physicians [80] interest groups [61] . Consensus of quality standards for antimi- hospitals. They sampled microbiologists and pharmacists to By written audit [82, 83] determine the practice of control measures for their respective Antimicrobial susceptibility reporting [84] hospital [68]; 49% responded. Among respondent hospitals, Reduction of pharmaceutical promotion [68] 86% had a P&T committee, 79% had an antibiotic formulary, 62% had a policy for therapy, and 17% had an antibiotic committee. In 40%, compliance was monitored, and 88% believed their policies for antimicrobial prophylaxis and therapy were Modern electronic communications and computers are revolutionizing hospital practice. In some hospitals, all medication beneficial. Policies included educational campaigns (52%), cost-control orders must be entered into computer terminals in the hospital or clinics. Such computerized order entry provides the opportuprograms (50%), regulation of pharmaceutical promotions (48%), therapeutic substitutions (43%), automatic stop orders nity for real-time physician-pharmacy interactions that otherwise would be impossible with a handwritten order. Although (26%), antibiotic utilization coordinators (11%), and antibiotic audit (11%). In a country that has had a national health service initial reports are encouraging, there is no consensus on the effect of computer-based drug utilization review on reducing for years, how would antimicrobial gatekeepers feel about developing national policies for control? Interestingly, very few antibiotic prescribing practices [62, 63] . Regardless of the value of computer-based drug utilization, increasingly sophisticated of the microbiologists (5.6%) and fewer pharmacists (0.7%) advocated a national policy. These attitudes are surprising, beinteractions now possible with computerized ordering will have a profound effect on physician prescribing and education in cause a report with recommendations from the Working Party of the BSAC in 1982 probably resulted in the high prevalence the future.
Control of antimicrobial resistance requires the implementaof control measures [68] . The minimum control measures that the BSAC now recomtion of two processes: infection control practices to limit the spread of resistant microorganisms and hospital policies of mends are summarized as follows: , has diverged from traditional approaches to implement control programs. In countermeasures exists at American hospitals. Leadership will be needed. This leadership should come from hospital epidemithe document, the authors speak of a ''striking lack of success in the prevention and control of antibiotic resistance despite ologists, microbiologists, pharmacists, physicians, infection control practitioners, and others who participate in the hospital career devotion by many health professionals to this objective.'' To quote further, ''Despite guidelines promulgated by committees providing recommendations. Hospital epidemiologists and others will need to present substantiating information the CDC and professional societies, antibiotic-restriction policies, and the entreaties of their colleagues, physicians continue to hospital administration on the morbidity, mortality, expense, and increased length of stay associated with antibiotic resisto prescribe antibiotics excessively and inappropriately. . . .'' As the authors note, although many American hospitals have tance. Hospital management will need to become invested in, and accountable for, the control of antibiotic resistance in hosa strategic policy for prevention and control of antibiotic resistance, very few hospitals have made antibiotic resistance a pitals, because certain processes and countermeasures are painful and expensive. strategic priority. Regardless of the reason for inaction by hospitals, we agree with the workshop participants that the time With the resistance crisis upon us, incremental change is likely to be ineffective, and a mass mobilization is needed to for complacency has long passed.
The workshop advanced two broad focus areas; each area curb the existing level of resistance. The current system of antibiotic use has resulted in the problem we face. Counterinvolved strategic goals with steps, process measures, and countermeasures to ensure success. Listed here are those goals acting forces constantly will come into play, e.g., the use of vancomycin for highly penicillin-resistant Streptococcus pneuthat involve implementation of an effective program of good antibiotic stewardship.
moniae will increase the selective pressure for the emergence of vancomycin-resistant enterococci. The expanding population The following are strategies to optimize the prophylactic, empiric, and therapeutic use of antibiotics in the hospital, conof neutropenic patients will increase the need for extendedspectrum cephalosporins and thus the likelihood of emergence sidering their impact on microbial environment, effectiveness, and cost:
of extended-spectrum b-lactamases. The development and testing of protocols for measuring the effect of a body, and input from national organizations (figure 1). Hospivariety of antimicrobial usage controls is recommended for use in multiple hospitals to determine the most effective ways to prevent and tal-specific formal guidelines then would be delivered from reduce antimicrobial resistance in specific species to specific these committees to the hospital administration for implementaantimicrobials.
tion. Staff compliance in individual facilities would be comPharmaceutical industry and governmental support for such studies is pared to quality improvement standards, and these outcomes recommended and encouraged.
would be the basis for continuous quality improvement.
It is recommended that educational methods, including those that are interactive and computer-based, be developed to improve the SHEA proposes that data provided by hospitals be utilized appropriateness of antimicrobial prescribing.
by state and national organizations, such as state health departIt is recommended that protocols to evaluate antimicrobial resistance include ments, the CDC, SHEA, and IDSA, to feed back information the ability to relate resistance rates to the ''defined drug density'' (the amount of antimicrobial used per geographic area per unit time). The transfer of resistance determinants in situ in a patient population is very poorly understood. First, the genetics of resistance transfer, the construction of composite transposons, and the actual mechanism of dissemination of these elements in situ, especially intergeneric transfer within the gram-positive bacteria, all should be studied further. Methods for interdicting transfer of resistance requires further study, especially in the behavioral area. Novel approaches to this area are needed. The efficacy of various levels of infection control precautions should be documented by controlled trials. Controlled studies of behavior modification, including novel approaches, to permit the efficient application of recommended guidelines within hospitals are recommended. The efficacy of quality improvement approaches to control of resistance should be studied.
important to the hospital for evaluating its own antimicrobialresistance policy. A state-supervised system of surveillance, like the one recently described in New Jersey, also would provide trends in emergence and spread of antibiotic-resistant organisms [71] . The Joint Commission on the Accreditation of Healthcare Organizations, or a similar review organization skilled in oversight functions, should take into account the priority hospitals give to antimicrobial resistance; policies, procedures, and measurements hospitals put into place; and evidence of ongoing review of data to judge the effectiveness of the plan. 
The Future
Outside review by JCAHO and other agencies is aimed specifically
Recognizing that our recommendations frequently are based at the implementation of recommendations, guidelines, and proposed policies, the primary responsibility of hospital administration.
on inadequate data, we call for funding for additional studies / 9c37$$se39 08-19-97 12:01:09 cida UC: CID
